Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

Covid Vaccine Battle Brewing: Moderna's Stephane Bancel Vs. Bernie Sanders

Moderna CEO Stephane Bancel will face off with Sen. Bernie Sanders on Wednesday over the Covid shot. The battle could rock Moderna stock.

Investors Business Daily

Moderna paid the US more than enough for COVID shot partnership, executive says

WASHINGTON — Moderna Inc. plans to tell U.S. lawmakers that it more than adequately compensated the government for its role in a COVID-19 vaccine partnership that brought the drugmaker billions of dollars, a central point in what’s likely to be a heated Capitol Hill hearing this week.

Tribune News Service

Sanders: "Medicare for All" must wait

As new chairman of the Senate HELP Committee, Sanders maps out his strategy for negotiating with GOP and Big Pharma

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna's COVID vaccine gambit: Hike the price, offer free doses for uninsured

Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.

WEKU

What are these 'cancer vaccines' I'm hearing about? And what similarities do they share with COVID vaccines?

Barely a month goes by without headlines announcing yet another advancement in cancer vaccines.

The Conversation

What are these ‘cancer vaccines’ making news? Are there similarities with COVID vaccines?

Using the same mRNA technology as COVID vaccines, cancer vaccines are an emerging personalised treatment for cancer.

The New Daily

Moderna eyes testing of mpox, bird flu vaccines in humans this year: 'They're really for public health'

A shot against mpox would be valuable in case outbreaks reemerge, and the company sees bird flu as a “clear threat,” the company's president said.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Cramlington's Merit enlisted for £150m Moderna vaccine hub scheme

Hundreds of construction jobs will be created through the Moderna Innovation and Technology Centre (MITC) project

Birmingham Post

12 'Dirt Cheap' Stocks Are Due For A Rally, Analysts Say

The S&P 500 isn't as cheap as it was — it's up 3.6% this year after all. But analysts still spot relatively bargain-priced stocks due to rally.

Investors Business Daily

The 'Edison Of Medicine' Shows You How To Get More Done

Robert Langer isn't impressed with incremental scientific milestones. The rock star scientist, known as the "Edison of Medicine," sets and usually reaches the loftiest of goals.

Investors Business Daily

Novavax Stock Plummets On 'Substantial Uncertainty' For Its Future

Novavax says there's "substantial doubt" regarding its ability to continue, and NVAX stock crashed Wednesday.

Investors Business Daily

8 Sinking Stocks Wipe The Smirks Off Millennials' Faces

Millennial investors might think investing is easy and "stocks only go up." But a few of their popular holdings are sinking fast.

Investors Business Daily

Is there a vaccine for RSV or respiratory syncytial virus? After almost 60 years, several come at once

You might not have heard of respiratory syncytial virus, or RSV. But it caused more than 100,000 global deaths in 2019, making it a leading cause of death in children under one year old.

The Conversation

Stock Market Sells Off As Hot Inflation Revives Fed Fears; Nvidia, Walmart, Home Depot Earnings In Focus: Weekly Review

The market rally is under increasing pressure as inflation revives and Fed fears mount. Nvidia spiked on earnings, but Walmart and Home Depot guided low.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

The Next Generation Of Cancer Vaccines Is Coming; What That Means For Moderna And Other Biotech Stocks

Startling cancer vaccine results from Moderna could drive the company's second act and usher in the next big thing in biotech. Here's what you need to know.

The Street

How the Minutes Set the Fed Up For the March Meeting

Investors digest the Federal Reserve minutes released Wednesday while reacting to earnings from Nvidia, Moderna and eBay. Watch TheStreet Today for more analysis on the market at 10:30 a.m. Eastern.

Investors Business Daily

The Covid Downfall Is Here: Moderna's Outlook Misses By More Than $2 Billion

Moderna stock toppled Thursday after missing guidance expectations by at least $2 billion as waning Covid shots champ at sales.

Investors Business Daily

Dow Jones Rises After Key Economic Data; Nvidia Surges On Earnings, But Lucid Plunges 17% On Sales Miss

The Dow Jones chased tech stocks higher Thursday after key economic data, Nvidia surged on earnings results, while Lucid plunged 14%.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Stocks Edge Higher, Nvidia, Moderna, eBay, Wells Fargo In Focus - Five Things To Know

Stock futures higher on Fed minutes relief, tech boost; Nvidia shares surge as AI chip demand powers solid sales outlook; Moderna earnings on deck as drugmaker looks past vaccine growth; eBay shares slump as muted outlook offsets Q4 earnings beat and Wells Fargo cutting more mortgage jobs as market extends…

Investors Business Daily

Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings

Moderna stock reversed lower Thursday after the FDA granted its Merck-partnered cancer vaccine a breakthrough designation.

Investors Business Daily

Dow Jones Futures Rise: Nvidia Earnings Lift Chips; S&P 500 Set To Bounce From Key Support

The S&P 500 tested its 50-day moving average Wednesday. Nvidia jumped late as the chip giant headlined overnight earnings.

Investors Business Daily

9 Stocks Jumped 200% In 3 Years Since Covid Rocked The World

It's been three years since the Covid crash tanked the S&P 500. But there's been still plenty of ways to make money since.

ABC News

A new bivalent COVID-19 booster rolls out next month. Here's what you need to know about the vaccine

All Australian adults who haven't had a COVID-19 booster or a confirmed case in the past six months are now eligible for an additional shot.

Investors Business Daily

Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees

Moderna stock toppled Friday on mixed results for its flu shot — a rival to experimental vaccines from BioNTech, CureVac and Sanofi.

The Street

Stocks Extend Slide, Moderna, DraftKings, Deere, Applied Materials In Focus - Five Things To Know

Stock futures extend slide as Treasury yields leap; Moderna slumps after mixed data from flu vaccine trial; DraftKings jumps on narrower Q4 loss, solid revenue outlook; Deere earnings on deck with global equipment demand in focus and Applied Materials sees AI chip demand support firmer Q2 sales.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.